|
DRUG INTERACTIONS
BENEFIX drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.
|
|
CONTRAINDICATIONS
Because BeneFIX® , Coagulation Factor IX (Recombinant), is produced in a Chinese hamster ovary cell line, it may be contraindicated in patients with a known history of hypersensitivity to hamster protein.
|
REFERENCES
-
Lusher JM. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol. 1991;28(3 Suppl. 6):3-5.
-
Shapiro AD, Ragni MV, Lusher JM, et al. Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B. Thromb Haemost. 1996;75(1):30-35.
-
Roberts HR, Eberst ME. Current management of hemophilia B. Hematol Oncol Clin North Am. 1993;7(6):1269-1280.
Wyeth®
Manufactured by:
Wyeth Pharmaceuticals Inc.
Philadelphia, PA 19101
US Govt. License No. 3
Imported and Distributed in Canada by:
Wyeth Canada
Montreal, Canada
W10483C005
ET01
Rev 07/04
|
|
|
-- advertisement --
|